3. Umbruch 4.4..2005 - Online Pot
3. Umbruch 4.4..2005 - Online Pot
3. Umbruch 4.4..2005 - Online Pot
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
270 Index<br />
met-fluoro-anandamide 168<br />
methanandamide 32, 187, 189<br />
(R)-methanandamide (AM-356) 32<br />
methyllevonantradol 188<br />
2-methylserotonin 187, 189<br />
microglia 87<br />
microglial activation 94<br />
microglial cell 55, 87, 96<br />
microglial cell migration and<br />
cannabidiol 55, 87<br />
microglial cell proliferation and<br />
migration 87<br />
migraine 10, 13, 14<br />
minor cannabinoid 239<br />
miscarrriage 72<br />
mitochondrial complex II 93<br />
mitochondrial dysfunction 79, 85,<br />
90, 92, 93<br />
mitogen activated protein kinase<br />
pathway 97<br />
model ANV, shrew 191, 192<br />
mood and overall sense of wellbeing<br />
247<br />
morning pain in rheumatoid arthritis<br />
247<br />
morphine 157, 187, 213<br />
mother plant 239<br />
mRNA expression 202<br />
multiple scelerosis (MS) 13, 16, 37,<br />
38, 79, 86, 89, 97, 99, 101, 144,<br />
233, 247, 250, 252–255, 259<br />
muscle relaxation 13<br />
muscle spam 247<br />
Na + /K + -ATPase 90<br />
Nabidiolex ® 242–244<br />
nabilone 185, 187, 188, 234<br />
NADA 156, 259<br />
N-arachidonoyl-dopamine 26, 234<br />
nausea, rat model 192–195<br />
nephritis 39<br />
neuralgia 10<br />
neuritic plaque 95, 96<br />
neurodegenerative diseases 37<br />
neurokinin1 (NK 1) 184<br />
neuropathic pain 13, 233, 247, 252–<br />
255, 259<br />
neuropathy 37<br />
neuroprotection 13, 54<br />
neurotransmission and cannabidiol<br />
50<br />
nicotine 213<br />
nigral dopaminergic neurons 93<br />
3-nitropropionic acid 92<br />
3-nitropropionic acid toxicity 92<br />
NMDA receptor 81, 83, 92, 95, 100<br />
NMDA-induced excitotoxicity 90<br />
N-methyl-D-aspartate (NMDA) 14<br />
N-methyllevonantradol 187<br />
NO 85–88, 93, 95, 97, 100<br />
NO donors 74<br />
NO synthase 83, 84, 86<br />
nocturia 16<br />
noladin ether 26, 234, 259<br />
non-cannabinoid fraction 241–243<br />
non-psychotropic cannabinoids 155<br />
noradrenergic signaling 202<br />
nuclear factor-κB (NF-κB) 86<br />
numerical rating scale 249<br />
obesity 219<br />
OL-135 157<br />
oleamide 26<br />
oligodendrocytes 98<br />
OMDM-1 157<br />
ondansetron 185, 190, 193, 194<br />
opiate sparing 247<br />
opium 11<br />
orexigenic action 91<br />
oromucosal cannabis-based<br />
medicine 16<br />
oromucosal spray 251<br />
osteoblast 201–203<br />
osteoblastic marker gene 202<br />
osteoclast 201, 202<br />
osteoclast differentiation 201, 202<br />
osteocyte 202<br />
osteogenic medium 202<br />
osteoporosis 201, 204<br />
ovariectomy 204
Change language